Dimethylformamide → Methyl 3-[3-[4-[4(3-trifluoromethylpheny)piperazin-1-yl]butyl]-2,4-dioxothieno[3,4-d]pyrimidin-1-yl]propanoate
反応式
[F:1][C:2]([F:31])([F:30])[C:3]1[CH:4]=[C:5]([N:9]2[CH2:14][CH2:13][N:12]([CH2:15][CH2:16][CH2:17][CH2:18][N:19]3[C:24](=[O:25])[C:23]4=[CH:26][S:27][CH:28]=[C:22]4[NH:21][C:20]3=[O:29])[CH2:11][CH2:10]2)[CH:6]=[CH:7][CH:8]=1.CN([CH:35]=[O:36])C>>[F:31][C:2]([F:1])([F:30])[C:3]1[CH:4]=[C:5]([N:9]2[CH2:10][CH2:11][N:12]([CH2:15][CH2:16][CH2:17][CH2:18][N:19]3[C:24](=[O:25])[C:23]4=[CH:26][S:27][CH:28]=[C:22]4[N:21]([CH2:22][CH2:23][C:24]([O:36][CH3:35])=[O:25])[C:20]3=[O:29])[CH2:13][CH2:14]2)[CH:6]=[CH:7][CH:8]=1参加物
3
実験手順
The title compound was produced following the procedure of Example 1 using 4.28 g (9.5 mmol) of 3-[4-[4-(3-trifluoromethylphenyl)piperazin-1-yl]butyl]thieno[3,4-d]pyrimidine-2,4-dione in DMF at 45° C. for 16 hours to produce methyl 3-[3-[4-[4(3-trifluoromethylpheny)piperazin-1-yl]butyl]-2,4-dioxothieno[3,4-d]pyrimidin-1-yl]propanoate in 80.5% yield (4.1 g).